Skip to main content
. 2021 Oct 17;11(10):e051277. doi: 10.1136/bmjopen-2021-051277

Table 2.

Pharmacists’ knowledge about generic drugs

Statement Yes or correct response, N (%) No or incorrect response, N (%) Unsure
N (%)
Were you aware that China carries out the programme of quality and efficacy consistency evaluation of generic drugs? 2118 (92.4) 74 (3.2) 99 (4.3)
Were you aware of the logo ‘Have passed the Consistency Evaluation’ on the generic products? 1718 (75.0) 320 (14.0) 253 (11.0)
True/false: in principle, the method of bioequivalence tests in vivo is used for consistency evaluation. The standard of bioequivalence is that the 90% CI of the geometric mean experiment/ reference ratios for main pharmacokinetic parameters (Cmax and AUC) falls entirely within the range of 90.00%~120.00%. 225 (9.8) 1666 (72.7) 400 (17.5)
Were you aware that all the generic drugs in national centralised procurement have passed the consistency evaluation of quality and efficacy? 2067 (90.2) 68 (3.0) 156 (6.8)
True/false: the generic drugs in the national centralised procurement have the same active ingredients, dosage forms, routes of administration and therapeutic effects with the brand drugs. 2078 (90.7) 57 (2.5) 156 (6.8)

AUC, area under concentration-time curve; Cmax, peak concentration.